NVS Novartis AG

NYSE
$155.21

Novartis AG (NVS) is expected to report earnings on January 26, 2027, before the market open. The consensus earnings estimate is $2.23 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.7% since its last earnings release on October 27, 2026.

Novartis AG Beat Consensus Estimates
Tuesday, October 27, 2026 · 12:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Jan 26
Tuesday · Before Open
Earnings Whisper
-
vs $2.23
Rev est $14.75B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $160.64

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Novartis AG

Novartis AG is engaged in the research, development, manufacturing and marketing of healthcare products and pharmaceuticals.

Sector

Healthcare

Industry

Drug Manufacturers / Major

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.